You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 94 23 486 or email: subscribe@krixos.com |
|
Most viewed
- 1. Pancreatic cancer: New drug extends lives but isn't a cure
- 2. New research links even low alcohol consumption to cancer, heart disease, and premature death
- 3. Unveiling a ceRNA Network Involving IL-8 and TNF-α in Active Generalized Vitiligo by Multi-Omics Integration
- 4. RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
- 5. Medicus Pharma Advances Teverelix® Program Towards Registrational Development Targeting High Cardiovascular-Risk Prostate Cancer Patients with Key European Submission
- 6. [68Ga]Ga-PentixaFor in Primary Aldosteronism: Billion-Dollar Potential in an Underserved Mass Market
- 7. Comparison of Cumulative Opioid Consumption Between Time-Programmed Decremental Infusion and Fixed-Rate Basal Infusion Modes of Intravenous Patient-Controlled Analgesia Following Mixed Surgery: Protocol for a Randomized Controlled Trial
- 8. EnGeneIC Honored with 2026 Breakthrough in Glioblastoma Biotech Award at Northwell Foundation Lenox Hill Neurosurgery Brain Cancer Gala in New York
- 9. Mayo Clinic study shows AI can reveal brain tumor risks without costly genetic testing
- 10. Curasight Announces Preliminary Readout from its Phase 1 Clinical Trial with uTREAT® in Aggressive Brain Cancer (Glioblastoma)
Last updated at 17:57 GMT
